123 related articles for article (PubMed ID: 6679653)
1. [Serum type III procollagen peptide in patients with pneumoconiosis].
Okazaki I; Maruyama K; Okuno F; Suzuki H; Aoyagi K; Sera Y
J UOEH; 1983 Dec; 5(4):461-7. PubMed ID: 6679653
[TBL] [Abstract][Full Text] [Related]
2. [Serum type III procollagen peptide in diagnosis of lung fibrosis due to silicosis and bleomycin toxicity].
Okuno F; Maruyama K; Okazaki I; Arai M; Suzuki H
J UOEH; 1986 Mar; 8 Suppl():355-61. PubMed ID: 2425407
[TBL] [Abstract][Full Text] [Related]
3. [Serum type III procollagen peptide in diagnosis of lung fibrosis due to silicosis and bleomycin toxicity].
Okuno F; Maruyama K; Okazaki I; Arai M; Suzuki H
J UOEH; 1985 Sep; 7(3):291-7. PubMed ID: 2416026
[TBL] [Abstract][Full Text] [Related]
4. Serum type III procollagen N-terminal peptide in coal miners.
Janssen YM; Engelen JJ; Giancola MS; Low RB; Vacek P; Borm PJ
Exp Lung Res; 1992; 18(1):1-8. PubMed ID: 1572317
[TBL] [Abstract][Full Text] [Related]
5. Serum type III procollagen peptide: indicator for pulmonary fibrosis: II. Application in 80 asbestos insulation workers.
Okazaki I; Maruyama K; Kobayashi Y; Lilis R; Suzuki Y
Am J Ind Med; 1987; 11(4):439-46. PubMed ID: 3578296
[TBL] [Abstract][Full Text] [Related]
6. [Significance of serum type III procollagen N-terminal peptide in patients with fibrotic lung disease].
Tanigawa S; Kinoshita Y; Kurosu H; Mogi M; Masutani M; Hayashi H; Okayasu M
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1194-201. PubMed ID: 3449674
[No Abstract] [Full Text] [Related]
7. Serum type III procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis.
Cavalleri A; Gobba F; Bacchella L; Luberto F; Ziccardi A
Br J Ind Med; 1988 Dec; 45(12):818-23. PubMed ID: 3219307
[TBL] [Abstract][Full Text] [Related]
8. Serum procollagen type III peptide in coal workers' pneumoconiosis: a five-year follow-up study.
Schins RP; Borm PJ
Exp Lung Res; 1994; 20(5):445-55. PubMed ID: 7843078
[TBL] [Abstract][Full Text] [Related]
9. Serum type III procollagen peptide: indicator for pulmonary fibrosis. I. A tool for early detection of pulmonary fibrosis as a complication in cancer therapy.
Okazaki I; Miura K; Kobayashi Y; Maruyama K; Yoshimatsu H; Tanaka T
Keio J Med; 1986 Jun; 35(2):107-15. PubMed ID: 3784237
[No Abstract] [Full Text] [Related]
10. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
[TBL] [Abstract][Full Text] [Related]
11. [Serum type III procollagen peptide in tissue fibrosis].
Maruyama K
Rinsho Byori; 1985 Jan; 33(1):27-32. PubMed ID: 3990010
[No Abstract] [Full Text] [Related]
12. [Application of serum type III procollagen peptide level in the diagnosis of lung fibrosis developed during bleomycin treatment in cancer patients].
Okazaki I; Miura K; Ohya S; Murakami M; Nagata N; Maruyama K; Kobayashi T; Okuno F; Oda S; Ito H
Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2104-11. PubMed ID: 2419464
[No Abstract] [Full Text] [Related]
13. Type III procollagen N-terminal peptides in experimental pulmonary fibrosis and human respiratory diseases.
Watanabe Y; Yamaki K; Yamakawa I; Takagi K; Satake T
Eur J Respir Dis; 1985 Jul; 67(1):10-6. PubMed ID: 2414122
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum type III procollagen peptide as an exposure marker in retired coal workers.
Schins RP; Lamers RJ; Préat B; Borm PJ
Int Arch Occup Environ Health; 1995; 66(6):413-9. PubMed ID: 7782126
[TBL] [Abstract][Full Text] [Related]
15. [N-terminal peptide of type III procollagen in serum and bronchoalveolar fluid as a marker of collagen metabolism in chronic interstitial lung diseases].
Siemińska A
Przegl Lek; 1996; 53(7):574-8. PubMed ID: 8975295
[TBL] [Abstract][Full Text] [Related]
16. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.
Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M
J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.
Bjermer L; Lundgren R; Hällgren R
Thorax; 1989 Feb; 44(2):126-31. PubMed ID: 2928996
[TBL] [Abstract][Full Text] [Related]
18. [N-procollagen(III)peptide and lysosomal beta-galactosidase in progressive scleroderma and silicosis].
Schulze E; Herrmann K; Haustein UF; Mehlhorn J; Böhme HJ
Dermatol Monatsschr; 1990; 176(11):687-93. PubMed ID: 2128055
[TBL] [Abstract][Full Text] [Related]
19. [Determination of blood procollagen III peptide as an early indicator of pulmonary fibrosis in exposure to asbestos].
Cavalleri A; Gobba FM; Ferrari D; Bacchella L; Candela S; Magnani N
Med Lav; 1988; 79(5):351-62. PubMed ID: 3252126
[No Abstract] [Full Text] [Related]
20. Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis.
Kikuchi K; Ihn H; Sato S; Igarashi A; Soma Y; Ishibashi Y; Takehara K
Arch Dermatol Res; 1994; 286(2):77-80. PubMed ID: 8154928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
